Two Federal Courts Reject Pfizer’s Federal Preemption Argument in cases involving Zoloft
Two Federal Courts Reject Pfizer’s Federal Preemption Argument in cases involving Zoloft Fri, 01 Apr 2005 With assistance from Daniel Troy as chief counsel of the FDA, Pfizer argued that state courts have no right to decide that a drug manufacturer can be held liable for not disclosing severe –…